A federal court has ordered Insulet to defend the target-date funds inside the employee retirement plan it sponsors, according to Bloomberg Law News.

The procedural ruling clears an Employee Retirement Income Security Act complaint to proceed past the motion-to-dismiss stage. A refusal to dismiss at this early point signals that the judge found the allegations plausible enough to support discovery.

What does this ruling change?

The order keeps the litigation alive on the merits. Insulet's plan fiduciaries must now respond to formal discovery requests, produce internal records on fund selection and monitoring, and potentially sit for depositions.

Insulet now joins a growing list of plan sponsors that have faced litigation over target-date fund selections rather than exiting the case at the threshold. An order to defend carries no finding of liability on the merits. Cases that survive dismissal usually resolve in settlement or on summary judgment rather than at trial.

Why target-date funds invite ERISA claims

Target-date funds pool stock and bond investments and shift toward conservative holdings as a participant's chosen retirement year approaches. Lawsuits over these funds typically argue that plan administrators chose options with elevated fees, weak performance records, or both, while overlooking cheaper or better-performing alternatives in the market.

The litigation pattern has touched plan sponsors across industries, from large public companies to mid-sized private employers. The central question rarely changes: did fiduciaries follow a reasoned process, and can they document it under oath?

Critics point to fee compression in the target-date market as evidence that cheaper options exist for nearly every retirement year. Plan sponsors counter that past performance, glide path design, and manager stability justify the chosen series even at slightly higher cost.

The plain takeaway: any company offering target-date funds in a 401(k) can find itself in court over the choice.

What HR and benefits leaders should watch

Three pressure points tend to determine outcomes in target-date fund cases:

• Total expense ratio of the chosen target-date series versus peers in the same vintage year
• Documented selection process in place before the funds entered the menu
• Pattern of periodic review and replacement when options consistently lag benchmarks

Fiduciaries with a paper trail of informed decisions typically defeat the claims or at least reach summary judgment. Sponsors without documented reasoning settle more often, regardless of the underlying fund quality.

For in-house benefits teams, the practical steps are largely already best practice. Benchmark fees annually. Capture meeting minutes from investment committee reviews. Retain analyst reports that informed each decision.

The plain takeaway: documented reasoning matters more than the specific funds chosen.

What the headline does not disclose

The Bloomberg Law News headline does not name the court, the plaintiff, the plan size, or the specific target-date series at issue. The dollar amount in controversy does not appear in the summary. Readers seeking the underlying complaint or the judge's reasoning must consult the full publication or the public docket.

A skeptic's caveat: a refusal to dismiss invites discovery, but it does not guarantee a win for the plaintiff at trial. Most ERISA fund-selection cases that clear this hurdle still resolve short of a published verdict, and judges often grant summary judgment where the record shows a documented process.

The plain takeaway: a headline that says "ordered to defend" tells HR only that the case is alive, not how the merits will play out.

Tom Whitfield covers retirement plan litigation and fiduciary issues for HR Briefing.